David Anthony Ostrowski

Mr. David Anthony Ostrowski

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 May 2023 in Journal of Pediatric Urology
Verified
Journal Article
Closed access
DODavid Anthony Ostrowski
David Anthony Ostrowski
JLJoseph R. Logan
Joseph R. Logan
MAMaria Antony
Maria Antony
RBReilly Broms
Reilly Broms
DWDana A. Weiss
Dana A. Weiss
JWJohn K. Weaver
John K. Weaver

24 July 2023 in Cancers
Verified
Journal Article
Open access
PDF file
DODavid Anthony Ostrowski
David Anthony Ostrowski
RCRaju Chelluri
Raju Chelluri
MHMatthew Herzig
Matthew Herzig
LXLeilei Xia
Leilei Xia
BCBrian Cortese
Brian Cortese
S. MalkowiczS. Malkowicz
S. Malkowicz
The ongoing Bacillus Calmette-Guérin (BCG) shortage has created challenges for the treatment of non-muscle invasive bladder cancer (NMIBCa). Our objective was to evaluate the efficacy of reduced-dose induction BCG (RD-iBCG) compared to full-dose induction BCG (FD-iBCG) regarding recurrence rates. We hypothesized that patients receiving RD-iBCG may recur at a higher rate compared to those who received FD-iBCG therapy. A retrospective review of all patients with NMIBCa treated with intravesical therapy at our institution between 2015–2020 was conducted. Inclusion criteria consisted of having a diagnosis of AUA intermediate or high-risk NMIBCa with an indication for a six-week induction course of FD or RD-BCG with at least 1 year of documented follow up. The data were censored at one year. Propensity score matching for age, sex, tumor pathology, and initial vs. recurrent disease was performed. The primary endpoint was bladder cancer recurrence, reported as recurrence-free survival. A total of 254 patients were reviewed for this study. Our final cohort was 139 patients after exclusion. Thirty-nine percent of patients had HGT1 disease. 38.6% of patients receiving RD-BCG developed a recurrence of bladder cancer within a one-year follow-up as compared to 33.7% of patients receiving FD therapy. After propensity matching, this value remained statistically significant (p = 0.03). In conclusion, RD-iBCG for NMIBCa is associated with a significantly greater risk of recurrence than full-dose induction therapy, suggesting that RD-iBCG may not be equivalent or non-inferior to full-dose administration in the short term.

19 July 2022 in Urology Case Reports
Verified
Journal Article
Open access
DODavid Anthony Ostrowski
David Anthony Ostrowski
BCBrian D. Cortese
Brian D. Cortese
RCRaju R. Chelluri
Raju R. Chelluri
RKR. Caleb Kovell
R. Caleb Kovell
AWAlan J. Wein
Alan J. Wein
DLDaniel J. Lee
Daniel J. Lee
Spontaneous rupture of a bladder diverticulum is a rare entity typically associated with tissue weakness, bladder outlet obstruction, increased intra-abdominal pressure, or inflammation. Diagnosis is most often achieved via cystogram with a reported role for pelvic ultrasound. Extraperitoneal ruptures are typically treated with catheterization and antibiosis while intraperitoneal ruptures are most frequently treated with immediate surgical intervention. In this case, an adult female presented with an intraperitoneal rupture with no clear inciting event with diagnosis confirmed by pelvic transvaginal ultrasound following a non-diagnostic cystogram. The patient was treated successfully with delayed open surgical repair.